Recon: FDA announces three leadership hires; Roche to invest $50B in US to avoid tariffs

• NIH director calls Trump’s anti-DEI orders ‘misunderstood,’ downplays reorganization plans (STAT)
• FDA Commissioner Marty Makary announces three new hires in leadership team (STAT)
• Trump looking at cutting US drug prices to international levels, sources say (Reuters)
• Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs (Endpoints)
• Reports Document FDA Review Delays: What Drugmakers Should Know Now (FDA Law Blog)

• Malnutrition treatments halted in Ethiopia due to underfunding, WFP says (Reuters)
• Getinge says tariffs will not change established supply chains (Reuters)
• ICH Modernizes Stability Testing Guideline (Pink Sheet)
• EU Biosimilar Filings, Opinions And Approvals (Pink Sheet)
• Israel steps up Gaza strikes; polio vaccination halted by blockade (Reuters) 

• Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobs (Reuters)
• Regeneron to invest over $3 billion to boost US manufacturing (Reuters)
• Billionaire Carl Icahn builds 34% economic interest in Bausch Health (Reuters)
• Danaher beats quarterly profit, expects incremental costs from US tariffs (Reuters)
• Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type (Reuters)
• Exclusive: George Church startup will study long-lived animals, humans to find life-extending genes (Endpoints)
• As the XBI suffers, Q1 shows a few comforting signs of underlying stability (Endpoints)
• Preventive health startup Superpower raises $30M (Endpoints)
• Leo pads case for chronic hand eczema nod with survey showing overwhelming effects on patient lives (Fierce Pharma)

• Quest beats quarterly profit estimates on strong demand for diagnostic tests (Reuters)
• FDA issues early alert for BD catheters due to leaks (MedTech Dive)
• Ceribell wins FDA nod for algorithm to detect pediatric seizures (MedTech Dive)
• Italy’s IMQ Designated As 15th Notified Body For IVDs (MedTech Insight)
• Migraine Relief Without A Pill: Click’s FDA Cleared CT-132 Turns Smartphone Into Therapy Tool (MedTech Insight)

• US FDA suspends milk quality tests amid workforce cuts (Reuters)
• Short-term diet trials are designed to fail (STAT)
• Researchers Develop Nanocage-Based Filter That Removes 90 Percent of PFAS From Groundwater (Food Safety)

• UnitedHealth discloses $1.7 million in security spending after slaying of top exec (STAT)
• Employers should continue waiving preventive care out-of-pocket costs regardless of how Supreme Court rules (STAT)
• Alvogen unit appeals court loss shielding Bausch Health's IBS drug from generics (Endpoints)
• US CDC ACIP Puts GSK’s Penmenvy Even With Pfizer, Prepares For Infant MedQuadFi, Lyme Vaccines (Pink Sheet)
• Confirmatory Trials: Industry Wants Timely Protocol Feedback, More Clarity On ‘Due Diligence’ (Pink Sheet)